Metabolic Acidosis Improves Airway Conductance in Patients with Asthma

The objective was to investigate whether acute metabolic acidosis could cause bronchodilation in patients with asthma. Twelve patients with asthma (8 females, mean age 39 (± SD 12) years, forced expiratory volume in 1 second [FEV1] 93 [±9] % predicted, PC20 1.9 (±1.0) mg/mL) participated in a double...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of asthma Jg. 46; H. 7; S. 656 - 658
Hauptverfasser: Brijker, F., Van Den Elshout, F. J.J., Bosch, F. H., Heijdra, Y. F., Folgering, H. Th.M.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Informa UK Ltd 01.01.2009
Taylor & Francis
Schlagworte:
ISSN:0277-0903, 1532-4303, 1532-4303
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The objective was to investigate whether acute metabolic acidosis could cause bronchodilation in patients with asthma. Twelve patients with asthma (8 females, mean age 39 (± SD 12) years, forced expiratory volume in 1 second [FEV1] 93 [±9] % predicted, PC20 1.9 (±1.0) mg/mL) participated in a double-blind, placebo-controlled trial. Subjects ingested calculated amounts of ammonium chloride to induce acidosis or saline as placebo, in random order, each on a separate day. Airway resistance (Raw), specific airway conductance (sGaw), FEV1, and PEF were measured as primary variables. To evaluate the consequences of alterations in bronchial contractility on the airway responsiveness, the histamine provocation test (PC20) was measured as secondary variable. The intervention resulted in a mean (SD) decrease in base excess from -0.5 (±1.4) to -3.9 (±1.1) mmol/L (p < 0.01) and a decrease in pH from 7.41 (±0.02) to 7.36 (±0.02) (p < 0.01). This caused a statistically significant increase in sGaw from 1.15 (±0.16) to 1.26 (±0.13) 1/kPa.s) (p < 0.05). Tendencies towards increase were found in PEF (7.79 (±2.2) versus 8.09 (±1.9) (NS, p = 0.10) and in FEV1 (2.98 (±0.9) versus 3.06 (±0.9) (NS, p = 0.15). PC20 did not change significantly. It was concluded that acute metabolic acidosis has a modest bronchodilating effect in patients with asthma.
AbstractList The objective was to investigate whether acute metabolic acidosis could cause bronchodilation in patients with asthma. Twelve patients with asthma (8 females, mean age 39 (+/- SD 12) years, forced expiratory volume in 1 second [FEV(1)] 93 [+/-9] % predicted, PC(20) 1.9 (+/-1.0) mg/mL) participated in a double-blind, placebo-controlled trial. Subjects ingested calculated amounts of ammonium chloride to induce acidosis or saline as placebo, in random order, each on a separate day. Airway resistance (R(aw)), specific airway conductance (sG(aw)), FEV(1), and PEF were measured as primary variables. To evaluate the consequences of alterations in bronchial contractility on the airway responsiveness, the histamine provocation test (PC(20)) was measured as secondary variable. The intervention resulted in a mean (SD) decrease in base excess from -0.5 (+/-1.4) to -3.9 (+/-1.1) mmol/L (p < 0.01) and a decrease in pH from 7.41 (+/-0.02) to 7.36 (+/-0.02) (p < 0.01). This caused a statistically significant increase in sG(aw) from 1.15 (+/-0.16) to 1.26 (+/-0.13) 1/kPa.s) (p < 0.05). Tendencies towards increase were found in PEF (7.79 (+/-2.2) versus 8.09 (+/-1.9) (NS, p = 0.10) and in FEV(1) (2.98 (+/-0.9) versus 3.06 (+/-0.9) (NS, p = 0.15). PC(20) did not change significantly. It was concluded that acute metabolic acidosis has a modest bronchodilating effect in patients with asthma.The objective was to investigate whether acute metabolic acidosis could cause bronchodilation in patients with asthma. Twelve patients with asthma (8 females, mean age 39 (+/- SD 12) years, forced expiratory volume in 1 second [FEV(1)] 93 [+/-9] % predicted, PC(20) 1.9 (+/-1.0) mg/mL) participated in a double-blind, placebo-controlled trial. Subjects ingested calculated amounts of ammonium chloride to induce acidosis or saline as placebo, in random order, each on a separate day. Airway resistance (R(aw)), specific airway conductance (sG(aw)), FEV(1), and PEF were measured as primary variables. To evaluate the consequences of alterations in bronchial contractility on the airway responsiveness, the histamine provocation test (PC(20)) was measured as secondary variable. The intervention resulted in a mean (SD) decrease in base excess from -0.5 (+/-1.4) to -3.9 (+/-1.1) mmol/L (p < 0.01) and a decrease in pH from 7.41 (+/-0.02) to 7.36 (+/-0.02) (p < 0.01). This caused a statistically significant increase in sG(aw) from 1.15 (+/-0.16) to 1.26 (+/-0.13) 1/kPa.s) (p < 0.05). Tendencies towards increase were found in PEF (7.79 (+/-2.2) versus 8.09 (+/-1.9) (NS, p = 0.10) and in FEV(1) (2.98 (+/-0.9) versus 3.06 (+/-0.9) (NS, p = 0.15). PC(20) did not change significantly. It was concluded that acute metabolic acidosis has a modest bronchodilating effect in patients with asthma.
The objective was to investigate whether acute metabolic acidosis could cause bronchodilation in patients with asthma. Twelve patients with asthma (8 females, mean age 39 (± SD 12) years, forced expiratory volume in 1 second [FEV1] 93 [±9] % predicted, PC20 1.9 (±1.0) mg/mL) participated in a double-blind, placebo-controlled trial. Subjects ingested calculated amounts of ammonium chloride to induce acidosis or saline as placebo, in random order, each on a separate day. Airway resistance (Raw), specific airway conductance (sGaw), FEV1, and PEF were measured as primary variables. To evaluate the consequences of alterations in bronchial contractility on the airway responsiveness, the histamine provocation test (PC20) was measured as secondary variable. The intervention resulted in a mean (SD) decrease in base excess from -0.5 (±1.4) to -3.9 (±1.1) mmol/L (p < 0.01) and a decrease in pH from 7.41 (±0.02) to 7.36 (±0.02) (p < 0.01). This caused a statistically significant increase in sGaw from 1.15 (±0.16) to 1.26 (±0.13) 1/kPa.s) (p < 0.05). Tendencies towards increase were found in PEF (7.79 (±2.2) versus 8.09 (±1.9) (NS, p = 0.10) and in FEV1 (2.98 (±0.9) versus 3.06 (±0.9) (NS, p = 0.15). PC20 did not change significantly. It was concluded that acute metabolic acidosis has a modest bronchodilating effect in patients with asthma.
The objective was to investigate whether acute metabolic acidosis could cause bronchodilation in patients with asthma. Twelve patients with asthma (8 females, mean age 39 (± SD 12) years, forced expiratory volume in 1 second [FEV 1 ] 93 [±9] % predicted, PC 20 1.9 (±1.0) mg/mL) participated in a double-blind, placebo-controlled trial. Subjects ingested calculated amounts of ammonium chloride to induce acidosis or saline as placebo, in random order, each on a separate day. Airway resistance (R aw ), specific airway conductance (sG aw ), FEV 1 , and PEF were measured as primary variables. To evaluate the consequences of alterations in bronchial contractility on the airway responsiveness, the histamine provocation test (PC 20 ) was measured as secondary variable. The intervention resulted in a mean (SD) decrease in base excess from -0.5 (±1.4) to -3.9 (±1.1) mmol/L (p < 0.01) and a decrease in pH from 7.41 (±0.02) to 7.36 (±0.02) (p < 0.01). This caused a statistically significant increase in sG aw from 1.15 (±0.16) to 1.26 (±0.13) 1/kPa.s) (p < 0.05). Tendencies towards increase were found in PEF (7.79 (±2.2) versus 8.09 (±1.9) (NS, p = 0.10) and in FEV 1 (2.98 (±0.9) versus 3.06 (±0.9) (NS, p = 0.15). PC 20 did not change significantly. It was concluded that acute metabolic acidosis has a modest bronchodilating effect in patients with asthma.
The objective was to investigate whether acute metabolic acidosis could cause bronchodilation in patients with asthma. Twelve patients with asthma (8 females, mean age 39 (+/- SD 12) years, forced expiratory volume in 1 second [FEV(1)] 93 [+/-9] % predicted, PC(20) 1.9 (+/-1.0) mg/mL) participated in a double-blind, placebo-controlled trial. Subjects ingested calculated amounts of ammonium chloride to induce acidosis or saline as placebo, in random order, each on a separate day. Airway resistance (R(aw)), specific airway conductance (sG(aw)), FEV(1), and PEF were measured as primary variables. To evaluate the consequences of alterations in bronchial contractility on the airway responsiveness, the histamine provocation test (PC(20)) was measured as secondary variable. The intervention resulted in a mean (SD) decrease in base excess from -0.5 (+/-1.4) to -3.9 (+/-1.1) mmol/L (p < 0.01) and a decrease in pH from 7.41 (+/-0.02) to 7.36 (+/-0.02) (p < 0.01). This caused a statistically significant increase in sG(aw) from 1.15 (+/-0.16) to 1.26 (+/-0.13) 1/kPa.s) (p < 0.05). Tendencies towards increase were found in PEF (7.79 (+/-2.2) versus 8.09 (+/-1.9) (NS, p = 0.10) and in FEV(1) (2.98 (+/-0.9) versus 3.06 (+/-0.9) (NS, p = 0.15). PC(20) did not change significantly. It was concluded that acute metabolic acidosis has a modest bronchodilating effect in patients with asthma.
Author Van Den Elshout, F. J.J.
Brijker, F.
Bosch, F. H.
Folgering, H. Th.M.
Heijdra, Y. F.
Author_xml – sequence: 1
  givenname: F.
  surname: Brijker
  fullname: Brijker, F.
  organization: 1Department of Pulmonology, Diakonessenhuis Utrecht, University of Nijmegen, The Netherlands
– sequence: 2
  givenname: F. J.J.
  surname: Van Den Elshout
  fullname: Van Den Elshout, F. J.J.
  organization: 1Department of Pulmonology, Diakonessenhuis Utrecht, University of Nijmegen, The Netherlands
– sequence: 3
  givenname: F. H.
  surname: Bosch
  fullname: Bosch, F. H.
  organization: 1Department of Pulmonology, Diakonessenhuis Utrecht, University of Nijmegen, The Netherlands
– sequence: 4
  givenname: Y. F.
  surname: Heijdra
  fullname: Heijdra, Y. F.
  organization: 1Department of Pulmonology, Diakonessenhuis Utrecht, University of Nijmegen, The Netherlands
– sequence: 5
  givenname: H. Th.M.
  surname: Folgering
  fullname: Folgering, H. Th.M.
  organization: 1Department of Pulmonology, Diakonessenhuis Utrecht, University of Nijmegen, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19728200$$D View this record in MEDLINE/PubMed
BookMark eNp9kF1rFDEUhoNU7Hb1B3gjc-Xd6MlkJjOD3iyL1UKLvajX4eSLTZlJapJx2X9vylZECwuBQM775JzzXJAzH7wh5C2FDxQG-AhN38MI5TQjZ5TCC7KiHWvqlgE7I6vHel2q7JxcpHQPUB6AvyLndOyboQFYkcsbk1GGyalqo5wOyaXqan6I4ZdJ1cbFPR6qbfB6URm9MpXz1S1mZ3xO1d7lXbVJeTfja_LS4pTMm6d7TX5cfrnbfquvv3-92m6ua9VCm2sth0a3oIdmoNqOknfS8q7vx3Zou0FaKrluNW-kBUa50ojKMpSc9qO1Eilbk_fHf8uEPxeTsphdUmaa0JuwJMF7zjpWZKzJu6fgImejxUN0M8aD-LN5CdBjQMWQUjT2bwTEo13xzG5h-v8Y5XKxEXyO6KaT5Ocj6bwNccZ9iJMWGQ9TiDYWsy4Jdgr_9A--MzjlncJoxH1Yoi_KTzT_Da6boc0
CitedBy_id crossref_primary_10_1139_y11_052
Cites_doi 10.1056/NEJM198404053101402
10.1152/jappl.1966.21.2.469
10.1152/jappl.1991.70.2.624
10.1378/chest.06-2898
10.1046/j.1365-2281.1999.00179.x
10.1152/jappl.1972.32.1.39
10.1046/j.1398-9995.2003.00313.x
10.1136/thx.42.1.45
10.1183/09041950.053s1693
10.1016/S0034-5687(00)00196-1
10.1164/ajrccm/136.1.225
10.1016/0014-2999(71)90085-9
10.1136/thx.46.1.28
ContentType Journal Article
Copyright 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009
Copyright_xml – notice: 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/02770900902963110
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-4303
EndPage 658
ExternalDocumentID 19728200
10_1080_02770900902963110
396483
Genre Research Article
Research Support, Non-U.S. Gov't
Controlled Clinical Trial
Journal Article
GroupedDBID ---
.55
.GJ
00X
03L
0BK
0R~
29J
36B
3O-
4.4
53G
5GY
5RE
5VS
AAJNR
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
AAUGY
ABBKH
ABEIZ
ABIVO
ABLKL
ABPTK
ABUPF
ABWCV
ABZEW
ACENM
ACFUF
ACGEJ
ACGFO
ACGFS
ACKZS
ACLSK
ADCVX
ADFCX
ADFOM
ADFZZ
ADRBQ
ADXPE
AECIN
AEGXH
AEIIZ
AENEX
AEOZL
AEYQI
AFFNX
AFKVX
AFLEI
AFWLO
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJVHN
AJWEG
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
AWYRJ
BABNJ
BLEHA
BOHLJ
BRMBE
CAG
CCCUG
COF
CS3
CYYVM
CZDIS
DKSSO
DRXRE
DU5
DWTOO
EBS
EJD
F5P
FEDTE
H13
HZ~
J.N
JENTW
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M44
M4Z
O9-
QQXMO
RNANH
RVRKI
SJN
TFDNU
TFL
TFW
UEQFS
V1S
X7M
ZGI
ZXP
~1N
AAGDL
AAJKZ
ABJNI
ABLIJ
ABWVI
ABXYU
ACIEZ
AFRVT
ALYBC
AQTUD
HVGLF
TASJS
TBQAZ
TDBHL
TERGH
TUROJ
AAORF
AAYXX
ACOPL
ACYZI
CITATION
NUSFT
ADYSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c404t-db82d40d8281df9b65bf6577948458bf1b6d4d62bf0316cdaacf3ab6179ffba13
IEDL.DBID TFW
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000269499900005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0277-0903
1532-4303
IngestDate Thu Oct 02 06:43:31 EDT 2025
Thu Apr 03 06:58:06 EDT 2025
Sat Nov 29 06:14:38 EST 2025
Tue Nov 18 21:40:05 EST 2025
Mon Oct 20 23:39:56 EDT 2025
Wed Jun 21 13:15:13 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c404t-db82d40d8281df9b65bf6577948458bf1b6d4d62bf0316cdaacf3ab6179ffba13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 19728200
PQID 67635396
PQPubID 23479
PageCount 3
ParticipantIDs crossref_primary_10_1080_02770900902963110
informaworld_taylorfrancis_310_1080_02770900902963110
informahealthcare_journals_10_1080_02770900902963110
pubmed_primary_19728200
crossref_citationtrail_10_1080_02770900902963110
proquest_miscellaneous_67635396
PublicationCentury 2000
PublicationDate 2009-01-01
PublicationDateYYYYMMDD 2009-01-01
PublicationDate_xml – month: 01
  year: 2009
  text: 2009-01-01
  day: 01
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The Journal of asthma
PublicationTitleAlternate J Asthma
PublicationYear 2009
Publisher Informa UK Ltd
Taylor & Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
References Chinn S (CIT0011) 1987; 42
Sterk P J (CIT0010) 1993; 16
Brijker F (CIT0005) 2001; 124
Pelzer A M (CIT0013) 1966; 21
van d en (CIT0016) 1991; 46
van d e (CIT0009) 1999; 19
(CIT0008) 1987; 136
Lindeman K S (CIT0004) 1991; 70
Duckles S P (CIT0002) 1974; 190
Sterling G M (CIT0012) 1972; 32
Boushey H A (CIT0006) 1980; 121
CIT0003
CIT0014
Larbanois A (CIT0015) 2003; 58
Pun L Q (CIT0001) 1971; 15
Quanjer P H (CIT0007) 1994; 11
References_xml – ident: CIT0003
  doi: 10.1056/NEJM198404053101402
– volume: 21
  start-page: 467
  year: 1966
  ident: CIT0013
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1966.21.2.469
– volume: 70
  start-page: 624
  year: 1991
  ident: CIT0004
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1991.70.2.624
– ident: CIT0014
  doi: 10.1378/chest.06-2898
– volume: 190
  start-page: 472
  year: 1974
  ident: CIT0002
  publication-title: J Pharmacol Exp Ther
– volume: 19
  start-page: 290
  year: 1999
  ident: CIT0009
  publication-title: Clin Physiol
  doi: 10.1046/j.1365-2281.1999.00179.x
– volume: 32
  start-page: 39
  year: 1972
  ident: CIT0012
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1972.32.1.39
– volume: 58
  start-page: 1256
  year: 2003
  ident: CIT0015
  publication-title: Allergy
  doi: 10.1046/j.1398-9995.2003.00313.x
– volume: 42
  start-page: 45
  year: 1987
  ident: CIT0011
  publication-title: Thorax
  doi: 10.1136/thx.42.1.45
– volume: 121
  start-page: 389
  year: 1980
  ident: CIT0006
  publication-title: Dis
– volume: 11
  start-page: 5
  year: 1994
  ident: CIT0007
  publication-title: Rev Mal Respir
– volume: 16
  start-page: 53
  year: 1993
  ident: CIT0010
  publication-title: Eur Respir J
  doi: 10.1183/09041950.053s1693
– volume: 124
  start-page: 151
  year: 2001
  ident: CIT0005
  publication-title: Respir Physiol
  doi: 10.1016/S0034-5687(00)00196-1
– volume: 136
  start-page: 225
  year: 1987
  ident: CIT0008
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/136.1.225
– volume: 15
  start-page: 110
  year: 1971
  ident: CIT0001
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(71)90085-9
– volume: 46
  start-page: 28
  year: 1991
  ident: CIT0016
  publication-title: Thorax
  doi: 10.1136/thx.46.1.28
SSID ssj0002706
Score 1.8115965
Snippet The objective was to investigate whether acute metabolic acidosis could cause bronchodilation in patients with asthma. Twelve patients with asthma (8 females,...
SourceID proquest
pubmed
crossref
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 656
SubjectTerms Acidosis - chemically induced
Administration, Oral
Adult
Airway Resistance - drug effects
Airway Resistance - physiology
Ammonium Chloride - administration & dosage
Ammonium Chloride - pharmacology
Ammonium Chloride - therapeutic use
asthma
Asthma - drug therapy
Asthma - physiopathology
Bronchial Hyperreactivity - drug therapy
Bronchial Hyperreactivity - physiopathology
bronchodilation
Double-Blind Method
Female
Forced Expiratory Volume - drug effects
Forced Expiratory Volume - physiology
Humans
Hydrogen-Ion Concentration - drug effects
In Vitro Techniques
Male
metabolic acidosis
Middle Aged
Peak Expiratory Flow Rate - drug effects
Peak Expiratory Flow Rate - physiology
specific airway conductance
Treatment Outcome
Title Metabolic Acidosis Improves Airway Conductance in Patients with Asthma
URI https://www.tandfonline.com/doi/abs/10.1080/02770900902963110
https://www.ncbi.nlm.nih.gov/pubmed/19728200
https://www.proquest.com/docview/67635396
Volume 46
WOSCitedRecordID wos000269499900005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAWR
  databaseName: Taylor & Francis Journals Complete
  customDbUrl:
  eissn: 1532-4303
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002706
  issn: 0277-0903
  databaseCode: TFW
  dateStart: 19810101
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV05T8MwFLagQoiF-yhH8cCEFOEkjuOMVUXF0qpDEd0inyISpKhOQfx77Bzl7gB7nMT29w6_9_w9AC4QYTxgSHsaCeRhRZCXSN9hWSHMpQoJFWWziXg4pJNJMqprc0xdVunO0Loiiih1tRNuxk1TEXfl0o4oQa6i0MLHLy9YWbPv-heM-3cLPRzEZWfNMknpohFNTvOnN3yySts1Z-n9ogLrC4_p795oaZX6W_-czzbYrN1R2K3wswNWVL4L1gd1wn0P9AeqsDB5yATsikxOTWZgFYdQBnaz2Qt7hb1p7khjHXxglsNRxdRqoAvxwq4p7h_ZPrjtX497N17desETGOHCk5wGEiNpz2O-1AknEdckiq3wUhxRrn1OJJYk4NoqBSIkY0KHjFt3KNGaMz88AK18mqsjAHnEKKdIcil9rK358ymzTiW1fkTMYkHaADVLn4qal9y1x3hI_Ya-9Ov6tMHlYshTRcqx7GH8bT_TWlDNsmHRxy1PizKAoqtuJ2m4ZNx5g43USqpLv7BcTecmJY77L0zshA8ryLz_exLbky9Cx3_85gnYqJJcLjJ0ClrFbK7OwJp4LjIz64DVeEI7pWy8AXhTBpY
linkProvider Taylor & Francis
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELVQQcAFyr7jAyekCKdxHOdYIaoiaMWhiN4iryJSSVEdQPw9dpay9wD3OPLyxh6_Gb8B4AQRxlsMaU8jgTysCPJi6TssK4S5VAGhoig2EfX7dDiMbyrCzVRple4OrUuhiGKvdsbtyOg6Je7MxR1RjFxKocWP715YzVs3IHQVDAadu-lO3IqK2ppFmNLxEXVU86dffDqXmpVq6f00B-uLkunv_mhxLnVW_zuiJlipPFLYLiG0BuZUtg4We1XMfQN0eiq3SBmlArZFKscmNbCkIpSB7XTywl7h-ThzurEOQTDN4E0p1mqgY3lh2-T3D2wT3HYuBuddr6q-4AmMcO5JTlsSI2mvZL7UMSch1ySMrP1SHFKufU4klqTFtd0XiJCMCR0wbj2iWGvO_GALNLJxpnYA5CGjnCLJpfSxtiegT5n1K6l1JSIWCbILUD33iaikyV2FjFHi1wqmX-dnF5xOmzyWuhyzPsbfFjSpbNXMahZ-XPMkLzgUXRY8SYIZ7Y5rcCTWWF0EhmVq_GQS4uT_gtgOeLvEzHvf48hefhHa-1tXj8FSd9C7Tq4v-1f7YLkMeTme6AA08smTOgQL4jlPzeSosJA3o0YJaw
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV05T8MwFLYQoIqF-748MCFFOI3jOGMFRCCg6lBEt8iniAQpqgOIf4-do0CBDrDHkY_v-Z3-HgBHiDDeZkh7GgnkYUWQF0vfYVkhzKUKCBVls4mo26WDQdyra3NMXVbpfGhdEUWUd7UT7iepm4q4E5d2RDFyFYUWPr57YDVHkLX8LZz7yd34Im5HZWvNMkvpwhFNUvOnX3xRS8s1aen9uARrgsj0d3O0VEvJ0j8XtAwWa3sUdioArYAZla-C1k2dcV8DyY0qLE4eMgE7IpNDkxlYBSKUgZ1s9Mre4Okwd6yxDj8wy2Gvomo10MV4YccU949sHdwm5_3TC6_uveAJjHDhSU7bEiNpHTJf6piTkGsSRlZ6KQ4p1z4nEkvS5treCkRIxoQOGLf2UKw1Z36wAWbzYa62AOQho5wiyaX0sbb6z6fMWpXUGhIRiwTZBqjZ-lTUxOSuP8ZD6jf8pZP7sw2Ox0OeKlaOaR_jb-eZ1pJqpg0LPx95WpQRFF21O0mDKeMOG2ykVlRd_oXlavhsUuLI_4LYLnizgszH3OPIur4I7fxtqoeg1TtL0uvL7tUuWKjyXS5ItAdmi9Gz2gfz4qXIzOiglI93hdAIIw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+acidosis+improves+airway+conductance+in+patients+with+asthma&rft.jtitle=The+Journal+of+asthma&rft.au=Brijker%2C+F&rft.au=van+den+Elshout%2C+F+J+J&rft.au=Bosch%2C+F+H&rft.au=Heijdra%2C+Y+F&rft.date=2009-01-01&rft.eissn=1532-4303&rft.volume=46&rft.issue=7&rft.spage=656&rft_id=info:doi/10.1080%2F02770900902963110&rft_id=info%3Apmid%2F19728200&rft.externalDocID=19728200
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-0903&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-0903&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-0903&client=summon